| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,080 | 0,096 | 11:16 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 10:33 | Observe Medical Secures Significant First Order from Portugal that Validates Expanded Product Portfolio Strategy | 1 | Oslo Børs | ||
| OBSERVE MEDICAL Aktie jetzt für 0€ handeln | |||||
| Do | Observe Medical ASA: Invitation to presentation with trading update 10 November 2026 | 1 | Oslo Børs | ||
| 30.09. | Observe Medical Announces Repeat Order for UnoMeter Safeti MAX Following Successful Customer Evaluation | 1 | Oslo Børs | ||
| 22.09. | OBSERVE MEDICAL ASA: Observe Medical Launches New Website to Strengthen Dialogue with Healthcare Decision-Makers Around Innovative UnoMeter Safeti Max | 1 | Cision News | ||
| 22.09. | Observe Medical Launches New Website to Strengthen Dialogue with Healthcare Decision-Makers Around Innovative UnoMeterT SafetiT Max | 1 | Oslo Børs | ||
| 16.09. | OBSERVE MEDICAL ASA: Correction - Responsibility Statement included in the Interim Report H1 2026 | 1 | Cision News | ||
| 16.09. | OBSERVE MEDICAL: Correction - Responsibility Statement included in the Interim Report H1 2026 | 1 | Oslo Børs | ||
| 10.09. | Observe Medical announces first order and the establishment of a distributor partnership in the attractive Philippine market | 1 | Oslo Børs | ||
| 25.08. | Observe Medical ASA: First half year 2026 interim report | 1 | Oslo Børs | ||
| 20.08. | OBSERVE MEDICAL ASA: Clinical article has been accepted for publication - UnoMeter Safeti Max | 1 | Cision News | ||
| 20.08. | OBSERVE MEDICAL: Clinical article has been accepted for publication - UnoMeter[TM] Safeti[TM] Max | 1 | Oslo Børs | ||
| 26.06. | OBSERVE MEDICAL ASA: Observe Medical - Company presentation with trading update | 1 | Cision News | ||
| 10.06. | Observe Medical ASA: Invitation to presentation with trading update 26 June, 2026 | 1 | Cision News | ||
| 29.05. | Observe Medical ASA - Annual General Meeting held | 1 | Cision News | ||
| 26.05. | OBSERVE MEDICAL ASA: Acceptance of Clinical Data for Scientific Publication - UnoMeter Safeti Max | 2 | Cision News | ||
| 08.05. | Observe Medical ASA - Notice of Annual General Meeting | 1 | Cision News | ||
| 30.04. | OBSERVE MEDICAL ASA: Observe Medical Annual Report for 2025 | 3 | Cision News | ||
| 30.04. | OBSERVE MEDICAL: Observe Medical Annual Report for 2025 | 1 | Oslo Børs |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ADAPTHEALTH | 6,065 | 0,00 % | Morning Market Movers: Ameresco, Inno Holdings, AdaptHealth, Ibotta See Big Swings | OTTAWA (dpa-AFX) - At 7:50 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 63,65 | 0,00 % | BMO Capital reiterates Outperform on BrightSpring Health stock | ||
| ALIGNMENT HEALTHCARE | 8,720 | +0,11 % | William Blair stuft Alignment Healthcare wegen Kostendruck und Rating-Herabstufung ab | ||
| HEARTFLOW | 47,590 | 0,00 % | Biotech Stocks At 52-Week Highs - Vaxcyte +31% On Phase 3 Results, InfuSystem, Illumina +7%, Charles River Laboratories +7%, HeartFlow +5% | SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.Vaxcyte Inc. (PCVX)Vaxcyte is... ► Artikel lesen | |
| BILLIONTOONE | 95,41 | 0,00 % | BillionToOne, Inc.: BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds | MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| FRESENIUS | 42,450 | +2,07 % | JEFFERIES stuft Fresenius SE auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Fresenius vor einem Treffen mit dem Chef Michael Sen auf "Buy" mit einem Kursziel von 55 Euro belassen. Die geschäftliche... ► Artikel lesen | |
| PROGYNY | 27,820 | -0,04 % | Progyny expects 1.2 million new covered lives in 2027 | ||
| FRESENIUS MEDICAL CARE | 37,490 | +2,10 % | Fresenius Medical Care: Helen Giza verlässt den Konzern - Nachfolger steht fest | Bad Marienberg (www.anleihencheck.de) - Ad hoc-Mitteilung der Fresenius Medical Care AG vom 07.10.2026:Der Aufsichtsrat der Fresenius Medical Care AG hat heute einstimmig beschlossen, Shervin J. Korangy... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 12,235 | 0,00 % | Aveanna Healthcare Holdings, Inc. - 8-K, Current Report | ||
| PRIVIA HEALTH GROUP | 20,180 | 0,00 % | Privia Health Group, Inc.: Privia Health to Report Third Quarter 2026 Results on Thursday, November 5 | ||
| GENEDX | 67,67 | 0,00 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| LIFESTANCE HEALTH GROUP | 12,060 | 0,00 % | Transcript: LifeStance Health Gr Q2 2026 Earnings Conference Call | ||
| BETA BIONICS | 17,440 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Announces Agreement Integrate the iLet Bionic Pancreas and mint with Senseonics' Eversense 365 | IRVINE, Calif., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced a partnership... ► Artikel lesen | |
| CONCENTRA GROUP | 36,670 | 0,00 % | Why Concentra's Quiet Healthcare Business Keeps Winning | ||
| SIEMENS HEALTHINEERS | 38,710 | +1,18 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen |